Skip to main content
SpringerLink
Log in

Combination Chemotherapy by Infusion in Solid Tumors

  • Chapter
Concomitant Continuous Infusion Chemotherapy and Radiation

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 69 Accesses

Abstract

Drug delivery by infusion is a promising avenue for improving the therapeutic index of several classes of drugs. Although the pharmacological rationale for infusional therapy has been long appreciated, relevant clinical trials have only recently begun to emerge, and only in a relatively few forms of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adelstein DJ, Sharan VM, Earle AS et al. (1986) Chemo- radiotherapy as initial management in patients with squamous cell carcinoma of the head and neck. Cancer Treat Rep 70: 761–767

    PubMed  CAS  Google Scholar 

  • Adelstein DJ, Sharan VM, Earle AS et al. (1988) Simultaneous radiotherapy and chemotherapy with 5- fluorouracil and cisplatin for locally confined squamous cell head and neck cancer. NCI Monogr 6: 347–351

    PubMed  Google Scholar 

  • Ahlgren JD, Trocki O, Gullo JJ et al. (1991) Continuous infusion 5-FU with weekly low-dose cisplatin as second- line therapy in patients with metastatic colorectal cancer who have failed 5-FU monotherapy. Cancer Investigation, 1990, in press

    Google Scholar 

  • Ajani J, McMurtrey M, Rich T et al. (1987) Combined modality therapy with effective prolonged systemic component for the locally advanced squamous cell carcinoma of the esophagus (SCCE). Proc ASCO 6: 82

    Google Scholar 

  • Alberts DS, Chen HSG, Liu R et al. (1978) Bleomycin pharmacokinetics in man. I. Intravenous administration. Cancer Chemother Pharmacol 1: 177–181

    Article  PubMed  CAS  Google Scholar 

  • Allen LM, Creaver PJ (1975) Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivatives. Eur J Cancer 11: 697–707

    Article  PubMed  CAS  Google Scholar 

  • Amrein PC, Weitzman SA (1985) Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil. J Clin Oncol 3:1632–1639

    PubMed  CAS  Google Scholar 

  • Ardalan B, Singh G, Silberman H (1988) A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-l- aspartic acid in patients with advanced pancreatic and colorectal cancers. J Clin Oncol 6: 1053–1058

    PubMed  CAS  Google Scholar 

  • Barranco SC, Humphrey RM (1971) The effects of bleomycin on survival and cell progression in Chinese hamster cells in vitro. Cancer Res 31: 1218–1223

    PubMed  CAS  Google Scholar 

  • Bergerat JP, Green C, Drewinko B (1979) Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using c/s-diammine- dichloroplatinum. Cancer Biochem Biophys 3: 173–180

    PubMed  CAS  Google Scholar 

  • Blumenreich MS, Woodcock TM, Gentile PS et al. (1987) High-dose cisplatin and vinblastine infusion with or without radiation therapy in patients with advanced non- small cell lung cancer. J Clin Oncol 5: 1725–1730

    PubMed  CAS  Google Scholar 

  • Bonomi P, Rowland KM Jr, Taylor SG IV et al. (1988) Phase II trial of therapy with etoposide, 5-fluorouracil by continuous infusion, cisplatin and simultaneous split- course radiation in stage III non-small cell bronchogenic carcinoma. NCI Monogr 6: 331–334

    PubMed  Google Scholar 

  • Cantrell JE, Hart RD, Taylor RF, Harvey JC (1987) Pilot trial of prolonged continuous infusion 5-fluorouracil and weekly cisplatin in advanced colorectal cancer. Cancer Treat Rep 71: 615–618

    PubMed  Google Scholar 

  • Carey RW, Hilgenberg AD, Wilkns EW et al. (1986) Prospective chemotherapy followed by surgery with possible postoperative radiotherapy in squamous cell carcinoma of the esophagus: evaluation of the chemotherapy component. J Clin Oncol 4: 697–701

    PubMed  CAS  Google Scholar 

  • Cavalli F, Sonntag RW, Jungi F et al. (1978) VP-16–213 monotherapy for remission induction in small cell lung cancer: a randomized trial using three dosage schedules. Cancer Treat Rep 62: 473–475

    PubMed  CAS  Google Scholar 

  • Choksi AJ, Hong WK, Dimery IW et al. (1988) Continuous cisplatin (24 hour) and 5-fluorouracil (120 hour) infusion in recurrent head and neck squamous cell carcinoma. Cancer 61: 909–912

    Article  PubMed  CAS  Google Scholar 

  • Cohen MH, Krasnow SH, Anderson AJ et al. (1987) Modified continuous infusion 5 flurouracil-platinum (CIF-P) in non-small cell lung cancer (NSCLC) patients. Proc ASCO 6: 185

    Google Scholar 

  • Coia LR, Engstrom PF, Paul A (1987) Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy. J Clin Oncol 5: 1783–1790

    PubMed  CAS  Google Scholar 

  • Cooper KR, Hong WK (1981) Prospective study of the pulmonary toxicity of continuously infused bleomycin. Cancer Treat Rep 65: 419–425

    PubMed  CAS  Google Scholar 

  • Cummings B, Keane T, Harwood A et al. (1984) Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation and chemotherapy. Cancer 54: 2062–2068

    Article  PubMed  CAS  Google Scholar 

  • Dasmahapatra KS, Citrin P, Hill GJ et al. (1985) A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck. J Clin Oncol 3: 1486–1489

    PubMed  CAS  Google Scholar 

  • Dillman RO, Seagren SL, Propert K et al. (1988) Proto- chemotherapy improves survival in regional non-small cell lung cancer (NSCLC). Proc ASCO 7: 195

    Google Scholar 

  • Dionet C, Verrelle P (1984) Curability of mouse L1210 leukemia by combination of 5-fluorouracil, cis- diamminedichloroplatinum (II) and low doses of x-rays. Cancer Rep 44: 652–656

    CAS  Google Scholar 

  • Downes CS, Mullinger EM, Johnson RT (1987) Action of etoposide (VP-16–213) on human cells: no evidence for topoisomerase II involvement in excision repair of u.v.- induced DNA damage, nor for mitrochondrial hypersensitivity in ataxia telangiectasia. Carcinogenesis 8: 613–618

    Article  Google Scholar 

  • Dy C, Gil A, Algana SA, et al. (1986) Combination chemotherapy of cisplatin and 5-FU in advanced colorectal carcinoma. Cancer Treat Rep 70: 465–468

    PubMed  CAS  Google Scholar 

  • Fraschini G, Yap HY, Barnes BC et al. (1982) Continuous five-day infusion of vinblastine for refractory metastatic breast cancer. Proc ASCO 1: 78

    Google Scholar 

  • Glick JH, Marcial V, Richter M, Velez-Garcia E (1980) The adjuvant treatment of inoperable stage III and IV epidermoid carcinoma of the head and neck with platinum and bleomycin infusions prior to definitive radiotherapy: an RTOG pilot study. Cancer 46: 1919–1924

    Article  PubMed  CAS  Google Scholar 

  • Goldberg RM, Jett JR, Therneau TM et al. (1990) Bolus versus infusin regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment Group. J Natl Cancer Dust 82: 1899–1903

    Article  CAS  Google Scholar 

  • Haas C, Byhardt R, Cox J et al. (1985) Randomized study of 5-fluorouracil (F) and cis-platinum (P) as initial therapy of locally advanced carcinoma of the head and neck (LASCHN). Proc ASCO 4: 143

    Google Scholar 

  • Hasketh PJ, Cooley TP, Finkel HE et al. (1988) Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin-C. Cancer 62: 1466–1470

    Article  Google Scholar 

  • Head and Neck Contracts Program (1987) Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Cancer 60: 301–311

    Article  Google Scholar 

  • Heim W, Brereton H, Shebaugh D (1986) Infusional high- dose cisplatinum and 5 fluorouracil in advanced non- small cell lung cancer: a Mid-Atlantic Oncology Program pilot study. Proc ASCO 5: 174

    Google Scholar 

  • Hilgenberg AD, Carey RW, Wilkens EW Jr et al. (1988) Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 45: 357–363

    Article  PubMed  CAS  Google Scholar 

  • Huau S, Singhakowinta A, Saual B, Pazdur R (1988) Efficacy of continuous infusion low-dose 5-FU (CILD- FU) in previously treated metastatic breast cancer. Proc ASCO 7: 37

    Google Scholar 

  • Huberman M, Lokich J, Green R et al. (1986) Vinblastine plus cisplatin in advanced non-small cell lung cancer: lack of advantage for vinblastine infusion schedule. Cancer Treat Rep 70: 287

    PubMed  CAS  Google Scholar 

  • Israel L, Bream JL, Morere JF (1987) Lung cancer. In: Lokich J J (ed) Cancer chemotherapy by infusion, 1st edn. Precept, Chicago, pp 338–352

    Chapter  Google Scholar 

  • Jabboury K, Holmes F, Theriault R, Hortobagyi G (1988) Fluorouracil rechallenge by protracted continuous infusion in refractory breast cancer. Proc ASCO 7: 39

    Google Scholar 

  • Jacobs C, Goffinet DR, Goffinet L et al. (1987) Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. Cancer 60: 1178–1183

    Article  PubMed  CAS  Google Scholar 

  • Jacobs C, Lyman G, Velez-Garcia E et al. (1988) Comparison of infusional 5 fluorouracil (5FU) and cisplatin (CDDP) in combination and as single agents for recurrent and metastatic head and neck cancer. Proc ASCO 7: 154

    Google Scholar 

  • Kies MS, Lester EP, Gordon LI et al. (1985) Cis-platin and infusion 5-fluorouracil (5-FU) in stage III and IV squamous cancer of the head and neck. Proc ASCO 4: 139

    Google Scholar 

  • Kies MS, Rosen ST, Tsang T-K et al. (1987) Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer 60: 2156–2160

    Article  PubMed  CAS  Google Scholar 

  • Kish J, Drelichman A, Jacobs J et al. (1982) Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep 66: 471–474

    PubMed  CAS  Google Scholar 

  • Kish JA, Weaver A, Jacobs J et al. (1984) Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53: 1819–1824

    Article  PubMed  CAS  Google Scholar 

  • Kish JA, Ensley JF, Jacobs J et al. (1985) A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 56: 2740–2744

    Article  PubMed  CAS  Google Scholar 

  • Krook J, Jett J, Little C (1987) A pilot study of infusion VP-16 followed by cisplatin (CDDP) in lung cancer. Proc ASCO 6: 182

    Google Scholar 

  • Kuebler JP, Hogan TF, Trump DL et al. (1984) Phase II study of continuous five-day vinblastine infusion in renal adenocarcinoma. Cancer Treat Rep 68: 925–926

    PubMed  CAS  Google Scholar 

  • Lee JS, Dhingra HM, Chiuten DF et al. (1987) A pilot study of etoposide (E), cisplatin (P) and 5-FU (F) continuous infusion (CI) for extensive non-small cell lung cancer (E-NSCLC). Proc ASCO 6: 173

    Google Scholar 

  • Leichman L, Steiger Z, Seydel HG et al. (1984) Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. J Clin Oncol 2: 75–79

    PubMed  CAS  Google Scholar 

  • Leichman L, Nigro N, Vaitkevicius VK et al. (1985) Cancer of the anal canal: model for preoperative combined modality therapy. Am J Med 78: 211–215

    Article  PubMed  CAS  Google Scholar 

  • Loehrer PJ, Turner S, Kubilis P et al. (1988) A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer. A Hoosier Oncology Group trial. J Clin Oncol 6: 642–648

    PubMed  Google Scholar 

  • Lokich JJ, Shea M, Chaffey J (1987) Sequential infusion of 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction. Cancer 60: 275–279

    Article  PubMed  CAS  Google Scholar 

  • Lokich JJ, Ahlgren JD, Gullo JJ et al. (1989a) A prospective randomized comparison of continuous-infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlanti Oncology Program Study. J Clin Oncol 7: 425–432

    PubMed  CAS  Google Scholar 

  • Lokich JJ, Cantrell J, Ahlgren J, Phillips J (1989b) A phase III trial of protracted infusional 5-FU (PIF) vs PIF plus weekly bolus cisplatin (CDDP) in advanced measurable colon cancer (MAOP protocol 5286). Proc ASCO 8: 104

    Google Scholar 

  • Lokich JJ, Cehlgren JD, Cantrell J, Gullo JJ, Fryer JG (1991) A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma: a Mid- Atlantic Oncology Program Study. Cancer (in press)

    Google Scholar 

  • Macmillan WE, Wobury WH, Welling PG (1978) Pharmacokinetics of 5-fluorouracil in humans. Cancer Res 38: 3479–3482

    PubMed  CAS  Google Scholar 

  • Meeker WR, Sickle-Santanello BJ, Philpott G et al. (1986) Combined chemotherapy, radiation and surgery for epithelial cancer of the anal canal. Cancer 57: 522–529

    Article  Google Scholar 

  • Michaelson R, Magill GB, Quan SHQ et al. (1983) Preoperative chemotherapy and radiation therapy in the management of anal epidermoid cancer. Cancer 51: 390–395

    Article  PubMed  CAS  Google Scholar 

  • Moertel C, Rubin J, O’Connell M et al. (1986) A phase II study of combined 5-fluorouracil, doxorubicin and cispla- tin in the treatment of advanced upper gastrointestinal adenocarcinomas. J Clin Oncol 4: 1053–1057

    PubMed  CAS  Google Scholar 

  • More re JF, Tcherakian F, Breau JL et al. (1988) Successful chemotherapy with cisplatinum (DDP) and 5- fluorouracil (5-FU) in small cell lung cancer. Proc ASCO 7: 210

    Google Scholar 

  • Murthy AK, Taylor SG IV, Showel J et al. (1987) Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy. Int J Radiat Oncol Biol Phys 13: 1807–1813

    Article  PubMed  CAS  Google Scholar 

  • Okuyama S, Mishina H (1980) Consecutive therapy of cancer aimed at perpetuation of repairable damage: a hypothesis unifying radiotherapy and chemotherapy. J Clin Hematol Oncol 10: 83–93

    Google Scholar 

  • Ortiz J, Wooley PV (1987) A study of the synergistic cytotoxic effects of 5-fluorouracil and cisplatin against colon carcinoma cells using median effect analysis. Proc AACR 28: 414

    Google Scholar 

  • Paredes J, Hong WK, Felder TB et al. (1988) Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbanate in recurrent and/or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 6: 955–962

    PubMed  CAS  Google Scholar 

  • Pennachio JL, Hong WK, Shapshay S et al. (1982) Combination of cisplatinum and bleomycin prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced squamous cell carcinoma of the head and neck. Cancer 50: 2795–2801

    Article  Google Scholar 

  • Perry D, Richard F II, Prospect K et al. (1987) 5-FU and cisplatin (DDP) vs 5-FU, DDP and vinblastine (VBL) in advanced non-small cell lung cancer (NSCLC). Proc ASCO 6: 168

    Google Scholar 

  • Poplin E, Fleming T, Leichman L et al. (1987) Combined therapies for squamous cell carcinoma of the esophagus, a Southwest Oncology Group study (SWOG-8037). J Clin Oncol 5: 622–628

    PubMed  CAS  Google Scholar 

  • Remick SC, Neville AJ, Willson JKV (1987) Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive disease small cell carcinoma of the lung. Cancer Treat Rep 71: 575–580

    PubMed  CAS  Google Scholar 

  • Richards F II, Beck J, Muss H et al. (1988) Continuous infusion 5-fluorouracil (5-FU) with bolus cisplatin (P) in the treatment of metastatic colorectal cancer. Proc ASCO 7: 96

    Google Scholar 

  • Roberts JJ, Thompson A J (1979) The mechanism of antitumor platinum compounds. Prog Nucleic Acid Res Mol Biol 22: 71–133

    Article  CAS  Google Scholar 

  • Rooney M, Kish J, Jacobs J et al. (1985) Improved complete response rate and survival in advanced head and neck cancer after three course induction therapy with 120-hours 5-FU infusion and cisplatin. Cancer 55: 1123–1128

    Article  PubMed  CAS  Google Scholar 

  • Rouniea PH, Oliveira J, Droz JP et al. (1988) Cisplatin (P) -I- five days continuous infusion 5-FU (c.i. 5FU) in advanced gastric cancer: preliminary results of a phase II trial. Proc ASCO 7: 106

    Google Scholar 

  • Rowland KM, Taylor SG IV, O’Donnell MR et al. (1984) Cisplatin/5-fluorouracil infusion chemotherapy in advanced recurrent cancer of the head and neck. Proc ASCO 3: 184

    Google Scholar 

  • Rowland K, Bonomi P, Taylor SG IV et al. (1988) Phase II trial of etoposide, cisplatin, 5-FU and concurrent split- course radiation in stages 3A and 3B non-small cell lung cancer (NSCLC). Proc ASCO 7: 203

    Google Scholar 

  • Schabel FM Jr, Trader MW, Laster WR et al. (1979) ds-Dichlorodiammineplatinum (II): combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep 63: 1459–1473

    PubMed  CAS  Google Scholar 

  • Shackney SE (1985) Cell kinetics and cancer chemotherapy. In Calabrisi P, Schein PS, Rosenberg SA (eds) Medical oncology. MacMillan, New York, pp 41–60

    Google Scholar 

  • Shah S, Harvey H, Lipton A et al. (1988) A randomized study of vinblastine and cisplatinum (VBL + CDDP) vs vinblastine, cisplatinum and 5-FU five day continuous infusion in advanced non-small lung cancer (NSCLC). Proc ASCO 7: 211

    Google Scholar 

  • Sikic B, Collins JM, Mimnaugh EG, Gram TE (1978) Improved therapeutic index of bleomycin when administered by continuous infusion in mice. Cancer Treat Rep 62: 2011–2017

    PubMed  CAS  Google Scholar 

  • Sischy B (1985) The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus and marginally resectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 11: 1587–1593

    Article  PubMed  CAS  Google Scholar 

  • Sischy B, Lefkopoulou M, Mittleman A et al. (1988) Interim report of EST 7283: a phase II study to evaluate the effectiveness of 5-FU and mitomycin-C combined with irradiation in the management of carcinoma of the anal canal. Proc ASCO 7: 107

    Google Scholar 

  • Stahelin H (1973) Activity of new glycosidic lignan derivative (VP-16–213) related to podophyllotoxin in experimental tumors. Eur J Cancer 9: 215–221

    Article  PubMed  CAS  Google Scholar 

  • Strauss G, Sherman D, Mathison D et al. (1988a) Concurrent chemotherapy (CT) and radiotherapy (RT) followed by surgery (S) in marginally resectable stage IIIA non- small cell carcinoma of the lung (NSCLC): a Cancer and Leukemia Group B Study. Proc ASCO 7: 203

    Google Scholar 

  • Strauss G, Schwartz J, Nickerson J, Lokich J (1988b) Continuous infusion (CI) 5-fluorouracil (5-FU) with or without cisplatin as third line therapy for metastatic breast cancer. Proc ASCO 7: 39

    Google Scholar 

  • Takita H, Regal AM, Antowiak JG (1987) Continuous five-day infusion of cis-platinum and 5-FU with methotrexate day one, in non-small cell lung carcinoma. Proc ASCO 6: 178

    Google Scholar 

  • Tannock IF, Browman G (1986) Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J Clin Oncol 4: 1121–1126

    PubMed  CAS  Google Scholar 

  • Taylor SG IV, Murthy AK, Showel JL et al. (1985) Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy. Cancer Treat Rep 69: 933–939

    PubMed  Google Scholar 

  • Taylor SG IV, Bonomi PD, Kiel KD et al. (1986) Failure of simultaneous cisplatin/5-FU infusion chemotherapy and radiation to improve control of esophageal cancer. Proc ASCO 5: 88

    Google Scholar 

  • Taylor SG IV, Trybula M, Bonomi PD et al. (1987) Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III non-small cell lung cancer. Ann Thorac Surg 43: 87–91

    Article  PubMed  Google Scholar 

  • Taylor SG IV, Murthy AK, Showel J et al. (1988a) Concomitant therapy with infusion of cisplatin and 5- fluorouracil plus radiation in head and neck cancer. NCI Monogr 6: 343–345

    PubMed  Google Scholar 

  • Taylor SG IV, Murthy AK, Bonomi P et al. (1988b) Concomitant therapy with infusional cisplatin and 5- fluorouracil plus radiation in stage III non-small cell lung cancer. NCI Monogr 6: 327–329

    PubMed  Google Scholar 

  • Weiden P, Piantadosi S (1988) Preoperative chemo- radiotherapy in stage III non-small cell lung cancer (NSCLC): a phase II study of the Lung Cancer Study Group (LCSG). Proc ASCO 7: 197

    Google Scholar 

  • Weiden PL, Einstein AB, Rudolph RH (1985) Cisplatin bolus and 5-FU infusion chemotherapy for non-small cell lung cancer. Cancer Treat Rep 69: 1253–1255

    PubMed  CAS  Google Scholar 

  • Wheeler C, Ervin T, Come S et al. (1986) Platinum, 5-FU and methotrexate (PFM): an active regimen in non-small cell lung cancer (NSCLC). Proc ASCO 5: 181

    Google Scholar 

  • Yap HY, Blumenschein BR, Keating MJ et al. (1980) Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer. Cancer Treat Rep 64: 279–283

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology-Oncology, The George Washington University, Medical Center, 2150 Pennsylvania Avenue, NW, Washington, DC, 20037, USA

    James D. Ahlgren MD (Associate Professor of Medicine)

Authors
  1. James D. Ahlgren MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. SUNY Health Science Center at Brooklyn, State University of New York, 450 Clarkson Ave., Box 1211, Brooklyn, 11203-2098, USA

    Marvin Rotman MD (Professor and Chairman, Dept. of Radiation Oncology) & C. Julian Rosenthal MD (Professor of Medicine and Oncology) (Professor and Chairman, Dept. of Radiation Oncology) &  (Professor of Medicine and Oncology)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ahlgren, J.D. (1991). Combination Chemotherapy by Infusion in Solid Tumors. In: Rotman, M., Rosenthal, C.J. (eds) Concomitant Continuous Infusion Chemotherapy and Radiation. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84186-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84186-6_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-84188-0

  • Online ISBN: 978-3-642-84186-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation